Key result
MTSET treatment alters Ca2+ transport in 35 NCKX2 mutants, revealing key ion access pathway residues.
Cysteine scanning mutagenesis and thiol-modifying reagents successfully mapped the ion access pathways of the human NCKX2 exchanger, identifying key residues critical for cation binding and transport.
Answers are grounded in this paper and cite their sources.
No immediate clinical implications; leaves open NCKX2 structural targeting for future human studies.
transport activity upon treatment with MTSET, with 16 showing near-complete inhibition and six demonstrating increased activity. Residues within the cation binding sites and extracellular access channels were sensitive to modification, consistent with their critical role in ion transport, whereas intracellular residues showed minimal accessibility to MTSET but were inhibited by membrane-permeable MTSEA. Water accessibility maps from MD simulations corroborated these findings, providing a high-resolution view of water-accessible pathways. This study provides a comprehensive structural and functional map of NCKX2 ion access pathways, offering insights into the molecular basis of ion selectivity and transport. These findings highlight the key residues critical for cation binding and transport, advancing our understanding of the structural dynamics of NCKX2.
No takes yet. Share an insight, caveat, or question.
Szerencsei et al. (2025) studied NCKX2 protein structure and function. MTSET and MTSEA thiol-modifying reagents vs. Wild-type NCKX2 or untreated was evaluated on Ca2+ transport activity. Treatment of 146 NCKX2 cysteine substitution mutants with MTSET resulted in significant changes in Ca2+ transport activity in 35 mutants, identifying key residues lining the ion access pathways.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: